Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Deficit

v3.19.1
Consolidated Statements of Stockholders' Deficit - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Beginning balance at Nov. 30, 2017 $ (12,502,896) $ 128,995 $ 31,373,048 $ (19,571,113) $ 40,865 $ (24,474,691)
Beginning balance, shares at Nov. 30, 2017   12,899,517        
Common stock issued 2,250 $ 13 2,237      
Common stock issued, shares   1,250        
Compensatory element of stock options 555,595   555,595      
Unrealized gain on available for sale securities 118,746       118,746  
Net income (2,530,072)         (2,530,072)
Ending balance at Feb. 28, 2018 (14,356,377) $ 129,008 31,930,880 (19,571,113) 159,611 (27,004,763)
Ending balance, shares at Feb. 28, 2018   12,900,767        
Beginning balance at Nov. 30, 2018 (8,908,298) $ 135,964 35,515,382 (19,571,113) 340,984 (25,329,515)
Beginning balance, shares at Nov. 30, 2018   13,596,409        
Common stock issued 5,700 $ 25 5,675      
Common stock issued, shares   2,500        
Compensatory element of stock options 138,982   138,982      
Cumulative-effect adjustment due to the adoption of ASU 2016-01 341,000          
Cumulative-effect adjustment due to the adoption of ASU 2016-01 | Accounting Standards Update 2016-01 [Member]         $ (340,984) 340,984
ASC 606 adoption adjustment, net of tax | Accounting Standards Update 2014-09 [Member] 253,447         253,447
Net income 275,877         275,877
Ending balance at Feb. 28, 2019 $ (8,234,292) $ 135,989 $ 35,660,039 $ (19,571,113)   $ (24,459,207)
Ending balance, shares at Feb. 28, 2019   13,598,909